September 12, 2025

NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 7.2025

Key Points

Recent updates to the NCCN Guidelines emphasize key treatment options for non-small cell lung cancer.
The guidelines highlight the role of systemic therapy in the management of nonmetastatic NSCLC patients.
Molecular testing considerations are critical for optimizing treatment strategies for NSCLC.
These insights enhance understanding of the evolving landscape in managing non-small cell lung cancer.

Abstract

The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of NSCLC. These NCCN Guidelines Insights discuss recent updates to the NCCN Guidelines, with a focus on systemic therapy options for the treatment of patients with nonmetastatic NSCLC and the corresponding molecular testing considerations.

Bookmark

Cite This Study

Riely et al. (Mon,) studied this question.

synapsesocial.com/papers/68d44f6931b076d99fa56469 https://doi.org/https://doi.org/10.6004/jnccn.2025.0043

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark